Rockville, Md. - A three-drug combination for the treatment of melasma is available as a single formula after being used separately since the 1970s.
Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Eczema Resources for Your Patients: Week 1
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD
Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies